Association between benzodiazepine use and dementia: A meta-analysis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Zhong, GuoChao ^a   Wang, Yi ^a   Zhang, Yong ^a   Zhao, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE;

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG USE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; PROSPECTIVE STUDY; PUBLIC HEALTH; RISK ASSESSMENT; AGED; CHEMICALLY INDUCED; META ANALYSIS; ODDS RATIO; RISK; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CASE-CONTROL STUDIES; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ODDS RATIO; PROSPECTIVE STUDIES; RISK; TIME FACTORS;

EID: 84959258545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127836     Document Type: Article

References (42)

1. World Health Organization. Dementia: a public health priority. World Health Organization; 2012.
2. Dell'osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European psychiatry: the journal of the Association of European Psychiatrists. 2013; 28(1):7-20.
3. Ashton H. The diagnosis and management of benzodiazepine dependence. Current opinion in psychiatry. 2005; 18(3):249-55. PMID: 16639148
4. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. Drugs & aging. 1994; 4(1):9-20.
5. Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). International psychogeriatrics /IPA. 2004; 16(4):461-80. PMID: 15715361
6. Mamdani M, Rapoport M, Shulman KI, Herrmann N, Rochon PA. Mental health-related drug utilization among older adults: prevalence, trends, and costs. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2005; 13(10):892-900. PMID: 16223968
7. Xiang YT, Ma X, Cai ZJ, Li SR, Xiang YQ, Guo HL, et al. The prevalence of insomnia, its sociodemographic and clinical correlates, and treatment in rural and urban regions of Beijing, China: a general population-based survey. Sleep. 2008; 31(12):1655-62. PMID: 19090321
8. European Medicines Agency. Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics. 1994.
9. Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology. 1997; 134(1):1-37. PMID: 9399364
10. Vinkers CH, Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators? Advances in pharmacological sciences. 2012; 2012:416864. doi: 10.1155/2012/416864 PMID: 22536226
11. Puustinen J, Nurminen J, Kukola M, Vahlberg T, Laine K, Kivela SL. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Drugs & aging. 2007; 24(12):1045-59.
12. Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). Journal of epidemiology and community health. 2012; 66(10):869-73. doi: 10.1136/jech-2011-200314 PMID: 22034632
13. Billioti de Gage S, Begaud B, Bazin F, Verdoux H, Dartigues JF, Peres K, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ (Clinical research ed). 2012; 345: e6231. doi: 10.1136/bmj.e6231 PMID: 23045258
14. Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2011; 19(2):151-9. doi: 10.1097/JGP.0b013e3181e049ca PMID: 20808131
15. Wu CS, Wang SC, Chang IS, Lin KM. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2009; 17(7):614-20. doi: 10.1097/JGP.0b013e3181a65210 PMID: 19546656
16. Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ (Clinical research ed). 2014; 349:g5205.
17. Fastbom J, Forsell Y, Winblad B. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer disease and associated disorders. 1998; 12(1):14-7. PMID: 9539405
18. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiologic reviews. 1987; 9:1-30. PMID: 3678409
19. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. Journal of the American College of Cardiology. 2011; 58(13):1378-85. doi: 10.1016/j.jacc.2011.06.024 PMID: 21920268
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21(11):1539-58. PMID: 12111919
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003; 327(7414):557-60. PMID: 12958120
22. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. The Stata Journal. 2006; 6(1):40-57.
23. World Health Organization. World Health Organization Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: WHO. 2000.
24. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. PMID: 7786990
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315(7109):629-34. PMID: 9310563
27. Lagnaoui R, Begaud B, Moore N, Chaslerie A, Fourrier A, Letenneur L, et al. Benzodiazepine use and risk of dementia: a nested case-control study. Journal of clinical epidemiology. 2002; 55(3):314-8. PMID: 11864804
28. Billioti de Gage S, Pariente A, Begaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert opinion on drug safety. 2015:1-15.
29. Bennett S, Thomas AJ. Depression and dementia: Cause, consequence or coincidence? Maturitas. 2014.
30. Mirza SS, de Bruijn RF, Direk N, Hofman A, Koudstaal PJ, Ikram MA, et al. Depressive symptoms predict incident dementia during short-but not long-term follow-up period. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2014.
31. Bocti C, Roy-Desruisseaux J, Roberge P. Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementia. BMJ (Clinical research ed). 2012; 345:e7986; author reply e93. doi: 10.1136/bmj.e7986 PMID: 23183062
32. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Annals of neurology. 2008; 64(5):492-8. doi: 10.1002/ana.21509 PMID: 19067364
33. Barbui C, Gastaldon C, Cipriani A. Benzodiazepines and risk of dementia: true association or reverse causation? Epidemiology and psychiatric sciences. 2013; 22(4):307-8. doi: 10.1017/S2045796013000358 PMID: 23823009
34. Petek Ster M, Cedilnik Gorup E. Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study. Croatian medical journal. 2011; 52(1):16-24. PMID: 21328716
35. Lesen E, Carlsten A, Skoog I, Waern M, Petzold M, Borjesson-Hanson A. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. International psychogeriatrics /IPA. 2011; 23(8):1270-7. doi: 10.1017/S1041610211000524 PMID: 21447258
36. Hsiao F-Y, Peng L-N, Lin M-H, Chen L-K. Dose-Responsive Effect of Psychotropic Drug Use and Subsequent Dementia: A Nationwide Propensity Score Matched Case-Control Study in Taiwan. Journal of the American Medical Directors Association. 2014.
37. Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and longterm use of hypnotics: a population-based retrospective cohort study. PloS one. 2012; 7(11):e49113. doi: 10.1371/journal.pone.0049113 PMID: 23145088
38. Parikh NM, Morgan RO, Kunik ME, Chen H, Aparasu RR, Yadav RK, et al. Risk factors for dementia in patients over 65 with diabetes. International journal of geriatric psychiatry. 2011; 26(7):749-57. doi: 10.1002/gps.2604 PMID: 20891020
39. Froehlich TE, Bogardus ST Jr., Inouye SK. Dementia and race: are there differences between African Americans and Caucasians? Journal of the American Geriatrics Society. 2001; 49(4):477-84. PMID: 11347796
40. Smith AD, Yaffe K. Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts. Journal of Alzheimer's disease: JAD. 2014; 38(4):699-703. doi: 10.3233/JAD-132372 PMID: 24326609
41. Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A. Benzodiazepines and injurious falls in community dwelling elders. Drugs & aging. 2008; 25(1):61-70.
42. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA: the journal of the American Medical Association. 1989; 262(23):3303-7. PMID: 2573741